Cargando…
Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients
Lymphoma is a chronic inflammatory disease in which the immune system is highly affected. Increased oxidative stress is one of the common conditions of cancer and affects macromolecules. Histone modifications affect the chromatin structure and functions. In this study, histone H1 (His-H1) protein wa...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174583/ https://www.ncbi.nlm.nih.gov/pubmed/35692834 http://dx.doi.org/10.3389/fgene.2022.909903 |
_version_ | 1784722269015113728 |
---|---|
author | Binsaleh, Naif K. Eltayeb, Reem Qanash, Husam Aziz, Mohammad Azhar Albaradie, Raid Khan, Mohd Wajid Ali |
author_facet | Binsaleh, Naif K. Eltayeb, Reem Qanash, Husam Aziz, Mohammad Azhar Albaradie, Raid Khan, Mohd Wajid Ali |
author_sort | Binsaleh, Naif K. |
collection | PubMed |
description | Lymphoma is a chronic inflammatory disease in which the immune system is highly affected. Increased oxidative stress is one of the common conditions of cancer and affects macromolecules. Histone modifications affect the chromatin structure and functions. In this study, histone H1 (His-H1) protein was modified by reactive oxygen species (ROS), and structural and chemical changes were studied. Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) patients were selected, and oxidative stress markers, inflammatory cytokines, and serum autoantibodies were analyzed using biochemical and immunological assays. Furthermore, the formation of antigen-antibody immune complexes was assessed by the Langmuir plot. ROS-modified His-H1 (ROS-His-H1) showed substantial structural perturbation in protein (UV-hyperchromicity and increased intrinsic fluorescence) compared to the native His-H1 protein. A possible explanation for the changes is suggested by the exposure of the aromatic chromophore to the solvent. In-depth structural analysis by circular dichroism (CD) exhibited major changes in α-helix (−21.43%) and turns (+33%), reflecting changes in the secondary structure of histone H1 protein after ROS exposure. ELISA and competitive ELISA findings revealed high recognitions of serum autoantibodies to ROS-His-H1 from NHL, followed by HL subjects. Healthy controls showed negligible binding. Non-modified His-H1 did not show any binding with serum samples from either cohort. High apparent association constants (ACCs) were calculated for ROS-His-H1 using purified IgGs from NHL (1.46 × 10(–6) M) compared to HL (1.33 × 10(–6) M) patients. Non-modified His-H1 exhibited a hundred times less ACC for NHL (2.38 × 10(–8) M) and HL (2.46 × 10(–8) M) patients. Thus, ROS modifications of histone H1 cause structural changes and expose cryptic neo-epitopes on the protein against which autoantibodies were generated. These perturbations might affect the histone DNA interaction dynamics and potentially be correlated with gene dysregulation. These subtle molecular changes with an immune imbalance might further aggravate the disease. |
format | Online Article Text |
id | pubmed-9174583 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-91745832022-06-09 Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients Binsaleh, Naif K. Eltayeb, Reem Qanash, Husam Aziz, Mohammad Azhar Albaradie, Raid Khan, Mohd Wajid Ali Front Genet Genetics Lymphoma is a chronic inflammatory disease in which the immune system is highly affected. Increased oxidative stress is one of the common conditions of cancer and affects macromolecules. Histone modifications affect the chromatin structure and functions. In this study, histone H1 (His-H1) protein was modified by reactive oxygen species (ROS), and structural and chemical changes were studied. Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) patients were selected, and oxidative stress markers, inflammatory cytokines, and serum autoantibodies were analyzed using biochemical and immunological assays. Furthermore, the formation of antigen-antibody immune complexes was assessed by the Langmuir plot. ROS-modified His-H1 (ROS-His-H1) showed substantial structural perturbation in protein (UV-hyperchromicity and increased intrinsic fluorescence) compared to the native His-H1 protein. A possible explanation for the changes is suggested by the exposure of the aromatic chromophore to the solvent. In-depth structural analysis by circular dichroism (CD) exhibited major changes in α-helix (−21.43%) and turns (+33%), reflecting changes in the secondary structure of histone H1 protein after ROS exposure. ELISA and competitive ELISA findings revealed high recognitions of serum autoantibodies to ROS-His-H1 from NHL, followed by HL subjects. Healthy controls showed negligible binding. Non-modified His-H1 did not show any binding with serum samples from either cohort. High apparent association constants (ACCs) were calculated for ROS-His-H1 using purified IgGs from NHL (1.46 × 10(–6) M) compared to HL (1.33 × 10(–6) M) patients. Non-modified His-H1 exhibited a hundred times less ACC for NHL (2.38 × 10(–8) M) and HL (2.46 × 10(–8) M) patients. Thus, ROS modifications of histone H1 cause structural changes and expose cryptic neo-epitopes on the protein against which autoantibodies were generated. These perturbations might affect the histone DNA interaction dynamics and potentially be correlated with gene dysregulation. These subtle molecular changes with an immune imbalance might further aggravate the disease. Frontiers Media S.A. 2022-05-25 /pmc/articles/PMC9174583/ /pubmed/35692834 http://dx.doi.org/10.3389/fgene.2022.909903 Text en Copyright © 2022 Binsaleh, Eltayeb, Qanash, Aziz, Albaradie and Khan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Binsaleh, Naif K. Eltayeb, Reem Qanash, Husam Aziz, Mohammad Azhar Albaradie, Raid Khan, Mohd Wajid Ali Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title | Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title_full | Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title_fullStr | Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title_full_unstemmed | Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title_short | Presence of Circulatory Autoantibodies Against ROS-Modified Histone H1 Protein in Lymphoma Patients |
title_sort | presence of circulatory autoantibodies against ros-modified histone h1 protein in lymphoma patients |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174583/ https://www.ncbi.nlm.nih.gov/pubmed/35692834 http://dx.doi.org/10.3389/fgene.2022.909903 |
work_keys_str_mv | AT binsalehnaifk presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients AT eltayebreem presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients AT qanashhusam presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients AT azizmohammadazhar presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients AT albaradieraid presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients AT khanmohdwajidali presenceofcirculatoryautoantibodiesagainstrosmodifiedhistoneh1proteininlymphomapatients |